Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-11-21
2006-11-21
Schultz, James (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A, C435S006120, C435S325000, C435S375000, C536S023100
Reexamination Certificate
active
07138517
ABSTRACT:
Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2′-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of diseases caused by various viruses and other causative agents is provided.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan et al.
patent: 4381344 (1983-04-01), Rideout et al.
patent: 4511713 (1985-04-01), Miller et al.
patent: 4689320 (1987-08-01), Kaji
patent: 4760017 (1988-07-01), McCormick
patent: 4876335 (1989-10-01), Yamane et al.
patent: 4908307 (1990-03-01), Rodland et al.
patent: 4965350 (1990-10-01), Inoue et al.
patent: 5013830 (1991-05-01), Ohtsuka et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5134066 (1992-07-01), Rogers et al.
patent: 5138045 (1992-08-01), Cook et al.
patent: 5149797 (1992-09-01), Pederson et al.
patent: 5212295 (1993-05-01), Cook
patent: 5214135 (1993-05-01), Srivastava et al.
patent: 5223618 (1993-06-01), Cook et al.
patent: 5256775 (1993-10-01), Froehler
patent: 5378825 (1995-01-01), Cook et al.
patent: 5386023 (1995-01-01), Sanghvi et al.
patent: 5466786 (1995-11-01), Buhr et al.
patent: 5491133 (1996-02-01), Walder et al.
patent: 5612215 (1997-03-01), Draper et al.
patent: 5623065 (1997-04-01), Cook et al.
patent: 5652355 (1997-07-01), Metelev et al.
patent: 5658731 (1997-08-01), Sproat et al.
patent: 5670633 (1997-09-01), Cook et al.
patent: 5804683 (1998-09-01), Usman et al.
patent: 5872232 (1999-02-01), Cook et al.
patent: 5891683 (1999-04-01), Usman et al.
patent: 5955589 (1999-09-01), Cook et al.
patent: 6060456 (2000-05-01), Arnold, Jr. et al.
patent: 2017369 (1990-11-01), None
patent: 39 15 462 (1990-09-01), None
patent: 3915462 (1990-09-01), None
patent: 41 10085 (1992-10-01), None
patent: 0 260 032 (1987-08-01), None
patent: 87307595.6 (1987-08-01), None
patent: 0 269 574 (1987-11-01), None
patent: 0 287 313 (1988-04-01), None
patent: 89303700.2 (1989-04-01), None
patent: 0 339 842 (1989-11-01), None
patent: 0 417 999 (1990-09-01), None
patent: 0788 366 (1995-10-01), None
patent: 3-240795 (1991-10-01), None
patent: WO 90/15814 (1990-12-01), None
patent: WO 91/06556 (1991-05-01), None
patent: WO 91/10671 (1991-07-01), None
patent: WO 91/12323 (1991-08-01), None
patent: WO 92/02258 (1992-02-01), None
patent: WO 92/03568 (1992-03-01), None
patent: WO 92/07065 (1992-04-01), None
patent: WO 92/22651 (1992-12-01), None
patent: WO 93/07883 (1993-04-01), None
patent: WO 94/00467 (1994-01-01), None
patent: WO 94/02498 (1994-02-01), None
patent: WO 94/02501 (1994-02-01), None
Arya, S. K. et al., “Inhibition of RNA Directed DNA Polymerase of Murine Leukemia Virus by 2′-O-Alkylated Polyadenylic Acids,”Biochemical and Biophysical Research Communications, 1974, 59(2), 608-615.
Arya, S. K. et al., “Inhibition of Synthesis of Murine Leukemia Virus in Cultured Cells by Polyribonucleotides and Their 2′-O-Alkyl Derivaties,”Molecular Pharmacology, 1976, 12, 234-241.
DeClercq, E. et al., “Influence of various 2- and 2′-substituted polyadenyl acids on murine leukemia virus reverse transcriptase,”Cancer Letters, 1979, 7, 27-37.
Hobbs, J. et al., “Polynucleotides Containing 2′-Amino 2′-deoxyribose and 2′-Azido-2′-deoxyribose†,”Biochem., 1973, 12, 5138-5145.
Hobbs, J. et al., Poly 2′-Deoxy-2′-Aminouridylic Acid, 1972, 46(4), 1509-1515.
Pieken, W. et al., “Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes,”Science, 1991, 253, 314-317.
Pilet, J. et al., “Structural parameters of single and double helical polyribonucleotides,”Biochem Biophys Res Commun, 1973, 52(2), 517-523.
Rottman, F. et al., “Polynucleotides Containing 2′- O-Methyladenosine. I. Synthesis by Polynucleotide Phosphorylase,”Biochem, 1968, 7, 2634-2641.
Rottman, F. et al., “Polymers Containing 2′-O-Methylnucleotides. II. Synthesis of Heteropolymers,”Biochem, 1969, 8(11), 4354-4361.
Wincott et al., “Synthesis, deprotection, analysis and purification of RNA and ribozymes,”Nucl. Acids Res., 1995, 23(14), 2677-2684.
Zmudzka, B. et al., “Poly 2′-O-methylcytidylic acid and the role of the 2′-hydroxyl in polynucleotide structure,”Biochem Biophys Res Commun, 1969, 37(6), 895-901.
Uesugi et al., “Studies of Nucleosides and Nucleotides-LXXXII.1)cyclonucleosides. (39).2)synthesis and properties of 2′halogen-2′-deoxyadenosines”,Chem. Pharm. Bull., 1978, 26, 2449-2453.
Ikehara et al., “A Linear Relationship Between Electronegativity of 2′-Substituents and Conformation of Adenine Nucleosides”,Tetrahedron Letters, 1979, 42, 4073-4076.
Ikehara et al., “Polynucleotides. LII.synthesis and properties of poly (2′-deox-2′-fluoroadenylic acid)”,Nucleic Acids Research, 1978, 5, 1877-1887.
Ikehara et al., “Studies of Nucleosides and Nucleotides-LXV1Purine Cyclonucleosides-26 A Versatile Method for the Synthesis of Purine O-Cyclo-Nucleosides. The First Synthesis of 8,21-Anhydro-8-Oxy 9-β-D-Arabinofuranosylguanine”,Tetrahedron, 1975, 31, 1369-1372.
Arnott et al., “Optimised Parameters for A-DNA and B-DNA”,Biochem. Biophys. Res. Comm., 1970, 47, 1504-1510.
Beaucage et al., “Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis”,Tetra. Lett., 1981, 22, 1859-1862.
Butke et al., “Facile synthesis of 2′-amino-2-deoxynucleoside from the corresponding arabino derivative”,Nucleic Acid Chemistry, 1986,Part Three, 149-152.
Eckstein, et al., “Polynucleotides containing 2′-chloro-2′-deoxyribose,”Biochemistry, 1972, 11, 4336-4344.
Fox, et al., “Nucleosides, XVIII. Synthesis of 2′-Fluorothymidine, 2′-fluorodeoxyuridine, and other 2′-halogeno-2′-deoxy nucleosides,”J. Org. Chem., 1964, 29, 558-564.
Ikehara et al., “Purine cyclonucleosides. (43). synthesis and properties of 2′halogen-2′-deoxyguanosines1)”,Chem. and Pharm. Bull., 1981, 29, 3281-3285.
Ikehara et al., “Polynucleotides. LVI. Synthesis and Properties of Poly(2′-deoxy-2′-fluoroinosinic Acid)”,Nucleic Acids Res., 1978, 5, 3315-3324.
De las Heras, et al., “3′-C-Cyano-3′-deoxythymidine,”Tet. Letts., 1988, 29, 941-944.
Ikehara et al., “Polynucleotides. L. synthesis and properties of poly (2′chloro-2′-deoxyadenylic acid) and poly (2′-bromo-2′-deoxyadentlic acid)”,Nucleic Acids Res., 1978, 4, 4249-4260.
Ikehara et., “Recognition by restriction endonucleaseEcoR1 of deoxyoctanucleotides containing modified sugar moieties”,European J. Biochem., 1984, 139, 447-450.
Inoue et al., “Synthesis and hybridization studies on two complementary nona(2′-O-methyl) ribonucleotides”,Nucleic Acid Res., 1987, 15, 6131-6148.
Jarvi et al., “Synthesis and biological evaluation of dideoxunucleosides containing a difluoromethylene unit”,Nucleosides&Nucleotides, 1989, 8, 1111-1114.
Koole et al., “Synthesis of phosphate-methylated DNA fragments using 9-fluorenylmethoxycarbonyl as transient base protecting group”,J. Org. Chem., 1989, 54, 1657-1664.
Jones et al., “4′-substituted nucleosides. 5. hydroxymethylation of nucleoside 5′-aldehydes”,J. Org. Chem., 1979, 44, 1309-1317.
Marcus-Sekura, “Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages”,Nucleic Acids Res.,
Cook Phillip Dan
Kawasaki Andrew Mamoru
Isis Patent Department
Isis Pharmaceuticals , Inc.
Schultz James
LandOfFree
Sugar modified oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sugar modified oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sugar modified oligonucleotides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3640071